Navigation Links
Pacira Pharmaceuticals' EXPAREL™ Data to be Featured at 2011 ASCPT 112th Annual Meeting
Date:3/2/2011

SAN DIEGO and PARSIPPANY, N.J., March 2, 2011 /PRNewswire/ -- Pacira Pharmaceuticals, Inc., (Nasdaq: PCRX), an emerging specialty pharmaceutical company, today announced that positive results from its Phase 1 study evaluating EXPAREL™ (bupivacaine extended-release liposome injection) in patients with moderate hepatic impairment, will be presented at the 2011 American Society for Clinical Pharmacology and Therapeutics (ASCPT) 112th Annual Meeting in Dallas, TX. Results from this Phase 1, open-label, parallel-group volunteer study demonstrated that the differences in plasma exposure of EXPAREL between subjects with moderate, stable hepatic impairment compared to subjects with normal hepatic function were small and unlikely to require a dose adjustment of EXPAREL.

The details for the Pacira poster presentation are as follows:

Date& Time: Thursday, March 3, 2011 from 7:30-9:30 a.m. (CST)

Poster Number: PI-67

Poster Title: Pharmacokinetics of Depobupivacaine (EXPAREL), a Novel Bupivacaine Extended-Release Liposomal Injection in Volunteers with Moderate Hepatic Impairment

Presenter: Erol Onel, MD, executive medical director, at Pacira Pharmaceuticals, Inc.

Following the presentation, the full poster will be available on Pacira's website at www.pacira.com.

In December 2010, Pacira announced that its New Drug Application (NDA) for EXPAREL had been accepted for filing by the U.S. Food and Drug Administration (FDA). Pacira submitted the EXPAREL NDA in September 2010 for the initial indication of postsurgical analgesia by local administration. The FDA has assigned a Prescription Drug User Fee Act (PDUFA) goal date of July 28, 2011 for the review of the EXPAREL NDA.

About EXPAREL™EXPAREL is Pacira's proprietary drug candidate consisting of bupivacaine enc
'/>"/>

SOURCE Pacira Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Total Knee Arthroplasty Presented at International College of Surgeons World Congress
2. Positive Phase II Study of Paciras EXPAREL(TM) (DepoBupivacaine) in Hernia Repair Presented at the Postgraduate Assembly in Anesthesiology (PGA)
3. Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment
4. Pacira Pharmaceuticals Announces FDA Acceptance of EXPAREL™ New Drug Application for Pain Management
5. Pacira Pharmaceuticals Presents New Data from EXPAREL Phase 3 Study at Orthopaedic Research Societys 57th Annual Meeting
6. Pacira Pharmaceuticals, Inc. Announces Pricing of Its Initial Public Offering
7. Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting
8. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
9. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
10. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)...  Numotion is pleased to announce the appointment of ... Mark is a 30-year retired veteran of GE ... organization and was a GE Company Officer since 1999 and ... years running business units within GE Healthcare, with the most ... "We are delighted to welcome Mark to our ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 ... available in its catalogue: Asia - ... http://www.reportlinker.com/p02353212/Asia---Pacific-Minimally-Invasive-Surgery-Spinal-Device-Market.html The growth rate ... MIS spinal device market will remain at double-digit levels ... spinal surgeries as the future of this field. The ...
(Date:9/2/2014)... Sept. 2, 2014 Depomed, Inc. (Nasdaq: ... offer, subject to market and other conditions, $230 million ... (the "Notes"). Depomed, Inc. ("Depomed") expects to grant the ... up to an additional $34.5 million aggregate principal amount ... RBC Capital Markets, LLC will act as joint book-running ...
Breaking Medicine Technology:Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 2Depomed Announces Offering of $230 Million Convertible Senior Notes Due 2021 3
... Decision Resources, one of the world,s leading research ... that biosimilar insulins and insulin analogues stand to erode ... Europe (France, Germany, Italy, Spain and U.K.) by 2018, ... , As insulins are relatively easy to develop and ...
... Corporation (Nasdaq: SMTS ) today announced that it ... Partners II, LLC ("Raba coreFoundry"). Under terms of ... specified rights of the U.S. Government and rights retained ... technology developed at The Johns Hopkins University. Integration ...
Cached Medicine Technology:Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 2Biosimilar Insulins and Insulin Analogues Stand to Erode $6.1 Billion in Brand Sales in the U.S. and Europe by 2018 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 2Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 3Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 4Somanetics Acquires Exclusive Sublicense to Cerebral Autoregulation Monitoring Technology Developed at The Johns Hopkins University 5
(Date:9/2/2014)... Fla. (PRWEB) September 02, 2014 ... join together in Tampa Bay from September 4-6 ... annual Scientific Symposium and FARA Energy Ball Gala. ... USF Ataxia Research Center in their pursuit of ... affected by the progressive neuromuscular disease Friedreich’s ataxia ...
(Date:9/2/2014)... Los Angeles, CA (PRWEB) September 03, 2014 ... helps health enthusiasts, bodybuilders, and athletes obtain the ... announced its launch. The site, which focuses mainly ... is dedicated to helping individuals increase their workout ... to an article available on Top Creatine Monohydrate, ...
(Date:9/2/2014)... UWDress.com, an experienced supplier of wedding dresses and women’s ... bridesmaid dresses for 2014 to its product ... offer to celebrate the coming autumn. All clients can ... off. , The company’s sales representative says, “We ... dresses for consumers from every part of the world. ...
(Date:9/2/2014)... September 02, 2014 Becker's Healthcare ... Center Educational Program on October 23-25, 2014 at ... Annual Meeting - The Business and Operations of ... through high-quality continuing education, networking events, and an ... technologies. , Outstanding educational offerings throughout the three-day ...
(Date:9/2/2014)... Recently, BambooIndustry.com, an excellent company in the ... strand woven bamboo floors to celebrate the coming ... appreciation to the frequent callers, BambooIndustry.com launched a promotion ... to strand woven floors, BambooIndustry.com provides many kinds of ... click strand woven floors, click lock floors, wide plank ...
Breaking Medicine News(10 mins):Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 2Health News:Event Gathers World-Renowned Researchers and Community Leaders to Find a Cure for Rare Disease, Friedreich’s Ataxia 3Health News:Creatine Monohydrate Reviews Site TopCreatineMonohydrate.com Announces its Launch 2Health News:Elegant Bridesmaid Dresses For 2014, Latest Designs From UWDress.com 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 2Health News:Becker's Healthcare Announces Ambulatory Surgery Center Educational Program 3Health News:Cheap Strand Woven Bamboo Floors For Autumn On Sale At BambooIndustry.com 2
... CIA Interrogation Tactics Confirms Severe and Long-Lasting Harm of Techniques ... ... 17, 2009 -- The newly released Bush Administration,s Office of ... involvement of health professionals in designing, supervising and implementing the ...
... Trauma Center and Neurological Intensive Care UnitATLANTA, April 17 ... gift to Grady Health System to improve emergency care ... The gift will enable Grady to expand hospital ... time-dependent therapies for stroke and acute neurological emergencies. ...
... SINGAPORE, April 17 /PRNewswire-Asia/ -- GfK Asia is pleased ... for the optical,industry today in line with the 14th ... to our recent survey in Malaysia, 25% of,consumers visit ... close to the,Asian average of 28%. "Despite the current ...
... cancer are well known, the risks they confer are ... access journal BMC Medicine describes the exact ... of colorectal cancer in a large group of patients. ... from the Universities of Bristol and Birmingham who studied ...
... Aurora Health Care ... replacement this morning. This first, in Wisconsin, ... reach thousands of viewers. (Photo: http://www.newscom.com/cgi-bin/prnh/20090416/CG00542 ... Aurora caregivers posted updates as "tweets" and answered ...
... SAN DIEGO, Calif., April 16 Join San Diego ... across the country, in making future healthcare decisions known ... Decisions Day is April 16. Now is a great ... directive, because... YOUR DECISIONS MATTER. What is ...
Cached Medicine News:Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 2Health News:OLC Memos Confirm Integral Role of Health Professionals in US Torture 3Health News:The Marcus Foundation Gives $20 Million to Grady Health System 2Health News:The Marcus Foundation Gives $20 Million to Grady Health System 3Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 2Health News:GfK Asia Releases First Ever Malaysian Contact Lens Industry Retail Measurement 3Health News:Colorectal cancer risks quantified 2Health News:Aurora Health Care Twitter-Surgery A Success 2Health News:Your Decisions Matter: San Diego Hospice Encourages You to Make Your Healthcare Decisions Known 2
... Chrome-plated metal frames ... ensures optimal cleanliness and ... stools come with user-friendly ... height adjustment. Fixed footring ...
... The ideal modular cleanroom for ... applications that require cleanliness (to Class ... are precision-joined to create ultra-smooth surfaces ... and disinfect. One-inch radius corners simplify ...
... cleanroom for biological safety labs (BSL) ... (to Class 10/ISO 3) and easy ... ultra-smooth surfaces that are easy to ... corners simplify cleaning. Unique double-wall panel ...
Inquire...
Medicine Products: